BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31097630)

  • 21. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
    Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
    Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
    Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
    Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
    Bone H; Williams NA
    Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
    Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
    J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation.
    Rombout A; Lust S; Offner F; Naessens E; Verhasselt B; Philippé J
    Br J Cancer; 2016 Mar; 114(6):704-12. PubMed ID: 26924423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
    Lazarian G; Yin S; Ten Hacken E; Sewastianik T; Uduman M; Font-Tello A; Gohil SH; Li S; Kim E; Joyal H; Billington L; Witten E; Zheng M; Huang T; Severgnini M; Lefebvre V; Rassenti LZ; Gutierrez C; Georgopoulos K; Ott CJ; Wang L; Kipps TJ; Burger JA; Livak KJ; Neuberg DS; Baran-Marszak F; Cymbalista F; Carrasco RD; Wu CJ
    Cancer Cell; 2021 Mar; 39(3):380-393.e8. PubMed ID: 33689703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
    Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
    Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway.
    Browning RL; Mo X; Muthusamy N; Byrd JC
    Oncotarget; 2015 Jun; 6(18):15931-9. PubMed ID: 26158860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.
    Romano MF; Lamberti A; Tassone P; Alfinito F; Costantini S; Chiurazzi F; Defrance T; Bonelli P; Tuccillo F; Turco MC; Venuta S
    Blood; 1998 Aug; 92(3):990-5. PubMed ID: 9680368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
    Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
    Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.
    Mazzarello AN; Gentner-Göbel E; Dühren-von Minden M; Tarasenko TN; Nicolò A; Ferrer G; Vergani S; Liu Y; Bagnara D; Rai KR; Burger JA; McGuire PJ; Maity PC; Jumaa H; Chiorazzi N
    J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34813501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
    Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
    J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
    Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
    Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
    Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
    Front Immunol; 2018; 9():1996. PubMed ID: 30271400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.
    Kirchner D; Duyster J; Ottmann O; Schmid RM; Bergmann L; Munzert G
    Exp Hematol; 2003 Jun; 31(6):504-11. PubMed ID: 12829026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT.
    Damdinsuren B; Dement-Brown J; Li H; Tolnay M
    Mol Immunol; 2016 May; 73():112-21. PubMed ID: 27065451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.